Reduced intensity treatment in early-stage Hodgkin’s lymphoma
Prathima Prodduturi, James O ArmitageUniversity of Nebraska Medical Center, Omaha, NE, USAAbstract: Early-stage Hodgkin’s lymphoma which includes patients with Ann Arbor stages I or II, accounts for more than 50% of all cases of the illness and is curable in a high proportion of patien...
Enregistré dans:
Auteurs principaux: | Armitage JO, Prodduturi P |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c4f4e07d307e47caa9d5db84f40d0989 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report
par: Provencio M., et autres
Publié: (2011) -
MEDICAL TREATMENT IN HODGKIN LYMPHOMA
par: Nilgun Kurucu
Publié: (2021) -
ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA
par: Sanda Buruiana, et autres
Publié: (2021) -
Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
par: John R. Krause, et autres
Publié: (2021) -
MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013)